ciprofloxacin has been researched along with pd 0305970 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bronstein, JC; Domagala, JM; Dunham, SA; Ellsworth, EL; Gage, JW; Gracheck, SJ; Hanna, DL; Huband, MD; Joannides, ET; Liu, JY; Nguyen, DQ; Sanchez, JP; Shapiro, MA; Showalter, HD; Singh, R; Stier, MA; Tran, TP; Watson, BM | 1 |
| Bird, P; Domagala, JM; Ellsworth, EL; Gracheck, SJ; Ha, C; Joannides, ET; Nguyen, DQ; Ramezani, S; Sanchez, JP; Shapiro, MA; Sharadendu, A; Showalter, HD; Singh, R; Stier, MA; Tran, TP; Watson, BM; Wu, X; Yip, J | 1 |
| Cohen, MA; Ellsworth, E; Gage, JW; Gibson, GW; Gracheck, SJ; Hanna, DL; Huband, MD; Skerlos, LA; Stier, MA; Sulavik, MC; Zurack, M | 1 |
| Ellsworth, EL; Ha, C; Huband, M; Hutchings, KM; Li, T; Maiti, S; Nguyen, DQ; Sanchez, JP; Shapiro, M; Showalter, HD; Singh, R; Stier, MA; Tailor, J; Themis Joannides, E; Thomas, G; Tran, TP; Watson, BM | 1 |
| Armstrong, D; Balibar, CJ; Bauer, D; Bellamacina, C; Benton, BM; Bussiere, D; De Pascale, G; De Vicente, J; Dean, CR; Dhumale, B; Fisher, LM; Fuller, J; Fulsunder, M; Holder, LM; Hu, C; Kantariya, B; Lapointe, G; Leeds, JA; Li, X; Lu, P; Lvov, A; Ma, S; Madhavan, S; Malekar, S; McKenney, D; Mergo, W; Metzger, L; Moser, HE; Mutnick, D; Noeske, J; Osborne, C; Patel, A; Patel, D; Patel, T; Prajapati, K; Prosen, KR; Reck, F; Richie, DL; Rico, A; Rivkin, A; Sanderson, MR; Satasia, S; Sawyer, WS; Selvarajah, J; Shah, N; Shanghavi, K; Shu, W; Skepper, CK; Thompson, KV; Traebert, M; Vala, A; Vala, L; Veselkov, DA; Vo, J; Wang, M; Widya, M; Williams, SL; Xu, Y; Yue, Q; Zang, R; Zhou, B | 1 |
5 other study(ies) available for ciprofloxacin and pd 0305970
| Article | Year |
|---|---|
3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms.
Topics: Anti-Bacterial Agents; Bacteria; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Positive Bacteria; Methicillin Resistance; Microbial Sensitivity Tests; Quinazolinones; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2006 |
Structure-activity relationships of 3-aminoquinazolinediones, a new class of bacterial type-2 topoisomerase (DNA gyrase and topo IV) inhibitors.
Topics: Amines; Anti-Bacterial Agents; DNA Gyrase; Gram-Positive Bacteria; Inhibitory Concentration 50; Quinazolinones; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2007 |
In vitro and in vivo activities of PD 0305970 and PD 0326448, new bacterial gyrase/topoisomerase inhibitors with potent antibacterial activities versus multidrug-resistant gram-positive and fastidious organism groups.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Resistance, Multiple; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Pyrrolidines; Quinazolinones; Topoisomerase II Inhibitors | 2007 |
Synthesis and antibacterial activity of the C-7 side chain of 3-aminoquinazolinediones.
Topics: Anti-Bacterial Agents; Combinatorial Chemistry Techniques; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Quinazolinones; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2008 |
Topoisomerase Inhibitors Addressing Fluoroquinolone Resistance in Gram-Negative Bacteria.
Topics: Anti-Bacterial Agents; Binding Sites; Cell Line, Tumor; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2020 |